Skip to main content
. 2015 Sep 15;7:477–488. doi: 10.2147/CEOR.S85213

Table S2.

Overall annual health care burden of RxO abuse: sensitivity analyses

Estimate France Germany Italy Spain United Kingdom
Sensitivity A Higher estimate of the percentage of opioid users entering treatment who misuse non-heroin opioids
Ci*
 Prevalence of RxO abuse (% of population aged 15–64 years) 0.391 0.220 0.015 0.015 0.215
Ki
 Population aged 15–64 years in 2010 (thousands) 41,001 54,610 39,735 31,389 40,871
Ji
 Per patient annual incremental health care costs of RxO abuse €1,737 €2,551 €1,437 €900 €1,501
Li* = Ci* × Ki × Ji
 Annual health care burden of RxO abuse €278.1 million €306.7 million €8.7 million €4.2 million €131.9 million
Sensitivity B Lower ratio of incremental health care costs of RxO abusers to those of matched control patients
Ci
 Prevalence of RxO abuse (% of population aged 15–64 years) 0.137 0.110 0.008 0.007 0.107
Ki
 Population aged 15–64 years in 2010 (thousands) 41,001 54,610 39,735 31,389 40,871
Ji#
 Per patient annual incremental health care costs of RxO abuse €529 €777 €438 €274 €457
Li# = Ci × Ki × Ji#
 Annual health care burden of RxO abuse €29.8 million €46.6 million €1.3 million €0.6 million €20.0 million
Sensitivity C Lower estimates of the annual health care costs of chronic pain conditions
Ci
 Prevalence of RxO abuse (% of population aged 15–64 years) 0.137 0.110 0.008 0.007 0.107
Ki
 Population aged 15–64 years in 2010 (thousands) 41,001 54,610 39,735 31,389 40,871
Ji
 Per patient annual incremental health care costs of RxO abuse €1,737 €772 €783 €603 €1,501
Li = Ci × Ki × Ji
 Annual health care burden of RxO abuse €97.9 million €46.3 million €2.4 million €1.3 million €65.7 million

Notes: All costs are reported in 2013 euros. Calculations for sensitivity A, sensitivity B, and sensitivity C are denoted with

*, #, and ‡,

respectively.

Abbreviation: RxO, prescription opioid.